Clin2
NCT06982131Possibly a fitRecruiting

Safety of RO7795081 and its effect on two statins

OverweightObesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests a new drug called RO7795081 to see if it changes how your body handles two common statins (pitavastatin and rosuvastatin). It is for adults who are overweight or obese but otherwise healthy, and aims to check the safety of the new drug.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
40 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are generally healthy, with a BMI of 27 or higher (overweight or obese).
  • Your weight has been stable (not changed by more than 5%) for the past 2 months.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.
  • You do not have serious medical conditions like heart disease, diabetes, epilepsy, or a history of seizures.
  • You do not have any condition that affects how your body absorbs or processes medications.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07495813Recruiting· Phase 1
Study of RO7763505 in healthy people and stable heart disease

This study tests an experimental drug (RO7763505) in healthy people and people with stable heart disease. It aims to see how safe the drug is and how it works in the body.

Groningen
NCT07785830Not yet recruiting· Phase 1
Study of a new drug with a common cholesterol medicine

This study tests how a new investigational drug, MK-4646, affects the levels of a common cholesterol medicine called rosuvastatin in healthy people. It helps researchers understand if the two drugs can be taken together safely.

NCT04903223Recruiting· Phase 1
Testing how fat in the liver affects statin use in kids

This early study tests whether “liver fat” changes how a statin (rosuvastatin) works in children and teens. It may help doctors choose safer or more effective dosing in kids based on biology and a specific genetics marker.

Kansas City, Missouri
NCT06804980Recruiting· Phase 4
Rosuvastatin Tolerance for People with Statin Side Effects

This trial tests a low dose of rosuvastatin (a common statin) in people who have had trouble with statins before. The goal is to see if your body can tolerate this specific dose again, which could help lower your cholesterol without the past side effects.

Minneapolis, Minnesota
NCT07001787Not yet recruiting· Phase 1
Safety study of HS-10510 in healthy volunteers

This trial tests a new drug called HS-10510 in healthy people to see if it is safe and how the body handles it. It is for healthy adults who meet specific weight and cholesterol levels.

NCT07401017Not yet recruiting
Rosuvastatin and running: a heart health study

This trial tests if the cholesterol-lowering drug rosuvastatin affects how your body adapts to running training. You may join if you are a long-distance runner who needs statin therapy and are willing to track your workouts with a sports watch.

Taipei

Hear when a new Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.